Elicio Therapeutics, Inc.

DB:9HA Stock Report

Market Cap: €49.8m

Elicio Therapeutics, Inc. Company Information

Elicio Therapeutics, Inc.'s employee growth, exchange listings and data sources

Key Information

  • Name: Elicio Therapeutics, Inc.
  • Ticker: 9HA
  • Exchange: DB
  • Founded: NaN
  • Industry: Biotechnology
  • Sector: Pharmaceuticals & Biotech
  • Market Cap: US$52.591m
  • Listing Market Cap: US$49.778m
  • Shares Outstanding: 10.78m
  • Website: https://elicio.com

Number of Employees

Location

  • Elicio Therapeutics, Inc.
  • 451 D Street
  • 5th Floor
  • Boston
  • Massachusetts
  • 02210
  • United States

Listings

TickerExchangePrimary SecuritySecurity TypeCountryCurrencyListed on
ELTXNasdaqCM (Nasdaq Capital Market)YesCommon StockUSUSDJun 2023
9HADB (Deutsche Boerse AG)YesCommon StockDEEURJun 2023

Company Analysis and Financial Data Status

All financial data provided by Standard & Poor's Capital IQ.
DataLast Updated (UTC time)
Company Analysis2024/11/27 20:28
End of Day Share Price 2024/11/27 00:00
Earnings2024/09/30
Annual Earnings2023/12/31


Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.